The criteria contain no weight at all
Read the diagnostic framework and the omission is obvious: irregular ovulation, androgen excess clinically or biochemically, polycystic ovarian morphology, two of three, after exclusions. Body weight appears nowhere among the features and nowhere among the exclusions. It is not a criterion, it is not a prerequisite, and it never was.
The association between PCOS and higher body weight is real at a population level and it is not part of the definition. Confusing a common accompaniment with a requirement is what produces the sentence that ends the appointment, and it is a straightforward misreading of the criteria rather than a defensible clinical position.
What 'lean PCOS' describes
It is not a separate diagnosis. It is an informal label for meeting the criteria at a body weight in the usual range, and reviews of the condition's heterogeneity describe phenotypes that occur at normal weight as part of the ordinary spread of presentations rather than as an exception requiring its own category.
The heterogeneity is the point. The condition is defined by combinations of features, and different combinations produce visibly different people — some with prominent skin and hair changes and regular-seeming cycles, some with markedly irregular cycles and few outward signs at all.
Metabolic features are documented independently of weight
This is the substantive reason the assumption causes harm rather than merely being annoying. The review literature on insulin sensitivity in PCOS reports reduced sensitivity occurring independently of body weight, alongside proposed mechanisms connecting it to androgen production. Being of normal weight does not exclude the metabolic feature, and assuming it does means the feature goes unmeasured.
The current guideline reflects that by recommending assessment of metabolic features as part of managing the condition rather than reserving it for those above a weight threshold. In other words, the test that most often goes unordered in this group is the one the guideline actually asks for.
Reduced insulin sensitivity is documented as occurring in this group; it is not universal within it. It is something to measure in an individual, not something to assume about them.
The Indian dimension
The evidence that metabolic risk in South Asian populations appears at lower body-mass index compounds the problem specifically here. If risk begins rising below the conventional overweight threshold, then a weight-based screening instinct will under-detect in this population generally — and it will under-detect hardest in exactly the group already being turned away for looking well.
That is a compounding of two separate errors: using weight as a proxy for a metabolic state, and using a threshold derived from a different population. Either alone would cause misses. Together they produce the specific, very common Indian experience of being visibly unwell, biochemically unexamined, and reassured.
Sources: [5]
What to bring so the appointment does not end early
A written cycle record over several months, which is the strongest evidence for the ovulation feature and is the thing most often reconstructed badly from memory in the room. A note of skin and hair changes with rough dates. Any previous scan report, and any previous hormone results with the dates they were taken on.
And a specific question rather than a general one. 'Am I overweight enough for this to be PCOS' invites the answer that ends the conversation; 'which of the three criteria have been assessed in my case, and which exclusions have been done' does not, because it is answerable and its answer is usually incomplete.
Sources: [2]
Where we fit, and where we do not
The reproductive diagnosis and its management sit with a treating gynaecologist, and fertility care is outside what this service does. That boundary is real and we would rather state it on the page than discover it after somebody has paid.
What a full metabolic panel read by a registered doctor adds is the half that a weight-based assumption most reliably skips: glucose handling, insulin, lipids, thyroid and liver markers, described for a specific person rather than assumed from their appearance. That is a useful thing to take back to the gynaecologist, not a replacement for them.
It is also worth being clear about what the panel cannot settle. It does not confirm or overturn a PCOS diagnosis, because two of the three diagnostic features are not blood tests at all — a cycle history and, where it is genuinely needed, a scan. What it does is describe the metabolic dimension of the same person with actual numbers, which is the part that a normal weight most reliably causes to go unexamined and the part that changes what food and training advice is worth giving.
Sources: [2]